BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1508427)

  • 1. Calcium-entry blockers-induced parkinsonism: possible role of inherited susceptibility.
    Negrotti A; Calzetti S; Sasso E
    Neurotoxicology; 1992; 13(1):261-4. PubMed ID: 1508427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism.
    Negrotti A; Calzetti S
    Mov Disord; 1997 Jan; 12(1):107-10. PubMed ID: 8990063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug-induced parkinsonism. Clinical aspects compared with Parkinson disease].
    Errea-Abad JM; Ara-Callizo JR; Aibar-Remón C
    Rev Neurol; 1998 Jul; 27(155):35-9. PubMed ID: 9674021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iatrogenic parkinsonism: the role of flunarizine and cinnarizine.
    Miguel R; Correia AS; Bugalho P
    J Parkinsons Dis; 2014; 4(4):645-9. PubMed ID: 25125483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis.
    Teive HA; Troiano AR; Germiniani FM; Werneck LC
    Parkinsonism Relat Disord; 2004 Jun; 10(4):243-5. PubMed ID: 15120099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
    Llau ME; Nguyen L; Senard JM; Rascol O; Montastruc JL
    Rev Neurol (Paris); 1994 Nov; 150(11):757-62. PubMed ID: 7597368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Movement disorders and depression due to flunarizine and cinnarizine.
    Micheli FE; Pardal MM; Giannaula R; Gatto M; Parera I; Paradiso G; Torres M; Pikielny R; Pardal J
    Mov Disord; 1989; 4(2):139-46. PubMed ID: 2733706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cinnarizine-induced parkinsonism: ten years later.
    Martí-Massó JF; Poza JJ
    Mov Disord; 1998 May; 13(3):453-6. PubMed ID: 9613736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Permanent non-progressive cinnarizine and flunarizine-induced parkinsonism: An under-recognized tardive syndrome in the elderly?
    Calzetti S; Negrotti A
    J Neurol Sci; 2023 Jan; 444():120526. PubMed ID: 36584558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug-induced or aggravated parkinsonism: clinical signs and the changing pattern of implicated drugs].
    Martí Massó JF; Poza JJ
    Neurologia; 1996 Jan; 11(1):10-5. PubMed ID: 8714170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cinarizine and Parkinson's disease. Double-blind placebo-controlled study].
    Martí Massó JF
    Neurologia; 1986; 1(2):55-7. PubMed ID: 3079110
    [No Abstract]   [Full Text] [Related]  

  • 12. Flunarizine- and cinnarizine-induced extrapyramidal reactions.
    Micheli F; Pardal MF; Gatto M; Torres M; Paradiso G; Parera IC; Giannaula R
    Neurology; 1987 May; 37(5):881-4. PubMed ID: 3574697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Parkinsonism, depression and akathisia induced by flunarizine, a calcium entry blockade--report of 31 cases].
    Kuzuhara S; Kohara N; Ohkawa Y; Fuse S; Yamanouchi H
    Rinsho Shinkeigaku; 1989 Jun; 29(6):681-6. PubMed ID: 2582681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug-induced parkinsonism].
    Kuzuhara S
    Nihon Rinsho; 1997 Jan; 55(1):112-7. PubMed ID: 9014432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinsonism, tremor, and depression induced by cinnarizine and flunarizine.
    Capellà D; Laporte JR; Castel JM; Tristán C; Cos A; Morales-Olivas FJ
    BMJ; 1988 Sep; 297(6650):722-3. PubMed ID: 3147743
    [No Abstract]   [Full Text] [Related]  

  • 16. Extrapyramidal symptoms after exposure to calcium channel blocker-flunarizine or cinnarizine.
    Jhang KM; Huang JY; Nfor ON; Tung YC; Ku WY; Lee CT; Liaw YP
    Eur J Clin Pharmacol; 2017 Jul; 73(7):911-916. PubMed ID: 28386684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug induced parkinsonism: a common cause of parkinsonism in older people.
    Thanvi B; Treadwell S
    Postgrad Med J; 2009 Jun; 85(1004):322-6. PubMed ID: 19528308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study.
    Taylor CA; Saint-Hilaire MH; Cupples LA; Thomas CA; Burchard AE; Feldman RG; Myers RH
    Am J Med Genet; 1999 Dec; 88(6):742-9. PubMed ID: 10581500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Parkinsonism due to the medication].
    Louter M; Tromp SC
    Ned Tijdschr Geneeskd; 2009; 153():A336. PubMed ID: 19900308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiology of parkinsonism in a Brazilian movement disorders clinic.
    Cardoso F; Camargos ST; Silva Júnior GA
    Arq Neuropsiquiatr; 1998 Jun; 56(2):171-5. PubMed ID: 9698723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.